Advanced Technologies and Intellectual Property Trends in ADC Research and Development
Currently, antibody-drug conjugate (ADC) therapy is experiencing a phase of robust development. Numerous ADC drugs have received regulatory approval for market launch globally and have demonstrated significant efficacy across various tumor types. However, ADC therapy also encounters several practical challenges, such as ensuring drug stability, managing toxicity, designing clinical trials, and controlling costs. To address these challenges, researchers and pharmaceutical companies must continuously explore innovative technologies and optimize the design and manufacturing processes of ADCs to enhance both the safety and efficacy of treatment.This report offers a comprehensive analysis of the pivotal technologies and novel components associated with ADC therapy. It examines the current thriving landscape, practical challenges, and future innovations in ADC therapy. Additionally, it explores the global patent environment, including detailed patent analyses and emerging trends. Finally, the report anticipates potential future research directions for ADC therapy.
